A New Era in Drug Development
Improve drug development and patient lives by eliminating anti-drug antibodies (ADAs) known to reduce drug efficacy and lead to adverse events
Become the premier drug development partner of choice with the first and only targeted solution that eliminates ADA
Leading the paradigm-breaking development of ADA-stealth protein therapeutics
Led by serial entrepreneurs with deep scientific expertise and a successful track record of biotech start-ups.
The world's first and only targeted solution for anti-drug antibodies (ADAs), a major un-breakable barrier to antibody, enzyme and gene therapies
OncoC4 spinoff leveraging scientific, manufacturing and clinical expertise of OncoC4
Copyright © 2025 AdaMunix, Inc. - All Rights Reserved.